Explore SkyCell SECURE
Learn what value SkyCell SECURE brings to your supply chain and schedule a demo.
Government influence in Green Pharma Logistics to boost savings made with SkyCell hybrid
Governments around the world are imposing fees upon those delivering goods unsustainably and introducing systems that advocate for sustainable packaging, meaning savings with SkyCell’s hybrid pharmaceutical containers are set to rise. With around 80% of medicines currently transported in throw-away packaging solutions like Styrofoam- (Expanded Polystyrene), PU- (polyurethane foam), VIP- (Vacuum insulated panels), PIR- (Polyisocyanurate insulation) containers, pharmaceutical manufacturers will see a spike in their overall logistics costs unless they move rapidly to more sustainable solutions.
Ever since the United Nations Paris Agreement in 2016, many countries have placed sustainability initiatives higher on their national agenda. Today, we await a distribution of medicine to solve a pandemic on a scale unlike any we have seen before. As Governments drive both sustainability efforts and preparation for pandemic logistics, the pharma industry is adapting to a new normal of increased Government involvement in their activities.
The key question is how to work towards both the goals of sustainability and resolution of the corona pandemic at one time. In the pharma logistics space, this requires a solution that’s both scalable and sustainable.
In Taiwan, the Government has imposed a Market Incentive (MI) system to encourage companies to increase their sustainability efforts and recycle wasteful packaging containers. With this subsidy policy, there is a financial reward for recycling many kinds of packaging containers, including iron, aluminum, paper, glass and plastic containers. In Germany, the German National Logistics Strategy includes legislative measures such as Energy Taxes, aimed at discouraging the inefficient use of fuel. In the EU more broadly, regulations for the mitigation of air pollution lay out strict and demanding standards for member states.
In pharma, the Paris Agreement had set forth a new era in the industry, one in which sustainability was no longer just a buzzword. This marginal increase in efforts led to pharma manufacturers switching from delivering medicine in single-use passive containers filled with ice to reusable active pharma containers. But as the potential distribution of a coronavirus vaccine dawns, the pharmaceutical industry is hearing a clear message that this model for medicine distribution still doesn’t match up to the needs of our businesses, people or the planet. Powered by external power sources such as electric sockets and convection fans to keep medicine cool, active container alternatives are still a drain on our resources.
Since the epoch of SkyCell’s hybrid container, its technology is proving to offer what the industry has been seeking – a scalable sustainable solution. Paving the way forward with both cost-cutting solutions and a reduction in environmental costs, hybrid containers self-charge independently of external power sources, cut CO2 by an average of almost 50% and reduce overall business costs by an average of 20%. With the rise of international, Government-led sustainability interventions, this is a saving that will only increase.
By eliminating redundant production and logistics costs, the hybrid solution already provides huge improvements for both business profits and our planet’s ecosystem. With the hybrid container reducing the costly spoilage of medical goods due to temperature excursions from between 4-12% to less than <0.1%, this is a huge leap forward towards a more sustainable future.
And with the upcoming need to distribute a coronavirus vaccine, it’s vital that SkyCell’s hybrid containers are reusable and benefit from quick release times through its technologically-enhanced compliance process before each new shipment.
Unfortunately, Internet Explorer does not support all the animations and features on this website. Please switch to another browser to enjoy a flawless user experience.